Medicare AdvantagePrior AuthMedium impact
Firazyr (icatibant) (Revised)
Humana·KY · Emergency Medicine, Allergy & Immunology·Medicaid
We identified it
Jul 23, 2026
Summary
Humana has issued a revised Prior Authorization policy for Firazyr (icatibant) affecting Medicare and Medicaid members in Kentucky. This is a medication-specific prior authorization requirement that billing teams must implement to avoid claim denials. The policy details appear limited in the summary provided, requiring immediate access to the full policy document for complete implementation guidance.
Action Required
Immediately: Billing team must access the full policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a5887aa to obtain the specific prior authorization requirements for Firazyr (icatibant). Update billing system to flag CPT/HCPCS code J1744 for prior authorization requirements before claim submission for Kentucky Medicaid and Medicare members. Notify providers and clinical staff of the prior authorization requirement. Any Firazyr claims submitted without prior authorization will likely be denied. Verify effective date and any member eligibility criteria from the full policy document.